Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/69893
Título: Challenges facing radiation oncologists in the management of older cancer patients: Consensus of the international geriatric radiotherapy group
Autores/as: Popescu, Tiberiu
Karlsson, Ulf
Vinh-Hung, Vincent
Trigo, Lurdes
Thariat, Juliette
Vuong, Te
Baumert, Brigitta G.
Motta, Micaela
Zamagni, Alice
Bonet, Marta
Myint, Arthur Sun
Lara Jiménez, Pedro Carlos 
Nguyen, Nam P.
Arenas, Meritxell
Clasificación UNESCO: 320101 Oncología
Palabras clave: Comorbidity
Discrimination
Frailty
Older
Radiotherapy Tolerance
Fecha de publicación: 2019
Publicación seriada: Cancers (Basel) 
Resumen: The management of older cancer patients remains difficult because of data paucity. Radiation oncologists need to identify potential issues which could affect treatment of those patients. A workshop was organized in Barcelona among international radiation oncologists with special interest in the management of older cancer patients on April 22, 2018. The following consensus was reached: 1. Older cancer patients often faced unconscious discriminating bias from cancer specialists and institutions because of their chronological age. 2. Advances in radiotherapy techniques have allowed patients with multiple co-morbidities precluding surgery or systemic therapy to achieve potential cure in early disease stages. 3. The lack of biomarkers for frailty remains an impediment to future research. 4. Access to healthcare insurance and daily transportation remains an issue in many countries; 5. Hypofractionation, brachytherapy, or stereotactic techniques may be ideally suited for older cancer patients to minimize transportation issues and to improve tolerance to radiotherapy. 6. Patients with locally advanced disease who are mentally and physically fit should receive combined therapy for potential cure. 7. The role of systemic therapy alone or combined with radiotherapy for frail patients needs to be defined in future clinical trials because of targeted agents or immunotherapy may be less toxic compared to conventional chemotherapy.
URI: http://hdl.handle.net/10553/69893
ISSN: 2072-6694
DOI: 10.3390/cancers11030371
Fuente: Cancers [ISSN 2072-6694], v. 11 (3), 371
Colección:Artículos
miniatura
Challenges_facing
Adobe PDF (257,21 kB)
Vista completa

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.